• ClearPoint Neuro (CLPT, Financial) has launched ClearPoint Navigation Software Version 3.0, broadening its market reach by enabling iCT-guided workflows in traditional operating rooms.
• The software maintains MRI-guided precision and has witnessed rapid early adoption among hospital sites.
• The new software supports several procedures, including biopsies, catheter and electrode insertion, and deep brain stimulation lead placement.
ClearPoint Neuro, Inc. (CLPT, Financial) announced the full market release of its ClearPoint Navigation Software Version 3.0, marking a significant shift in neurosurgical navigation technology. This upgrade introduces intraoperative CT (iCT) guidance capabilities, making the software accessible for traditional operating rooms without the need for specialized MRI infrastructure. The innovation is positioned to enhance procedure accessibility while maintaining the high precision synonymous with MRI-guided solutions.
The software's compatibility with standard iCT scanners has led to successful early adoption during its market release, indicating a strong positive reception from medical professionals. Dr. Ellen Air from Henry Ford Health supports the software's effectiveness, stating that it achieves precise placement comparable to MRI guidance, thus not compromising on accuracy.
This development allows more hospitals to perform procedures such as biopsies, catheter and electrode insertions, and deep brain stimulation (DBS) lead placements both asleep and awake, broadening ClearPoint Neuro's market reach. Dr. Arjun Khanna, a neurosurgeon in San Diego, has recognized the software's accuracy and efficiency, expressing a preference to use it as a default navigation tool for DBS lead placements.
The ClearPoint Navigation Software Version 3.0 will be featured at the American Academy of Neurological Surgeons Annual Meeting in Boston from April 25-28, 2025, reflecting ClearPoint's commitment to advancing neurosurgical technology and expanding its application in various clinical settings.
